Pekka Tuomola

TL;DR: Methylphenidate is an effective treatment for reducing intravenous drug use in patients with severe amphetamine dependence and should be considered as a treatment for nausea, vomiting, and diarrhea.

TL;DR: Naltrexone implants resulted in higher retention in the study, decreased heroin and amphetamine use, and improved clinical condition for patients, thus providing the first evidence of an effective pharmacological treatment for this type of polydrug dependence.

TL;DR: In this article, the efficacy of methylphenidate as a substitution therapy for amphetamine/methamphetamine dependence in Finland and New Zealand was evaluated in a parallel-group, double-blind, randomized placebo-controlled trial.

TL;DR: The four leading causes of death among illicit drug users are preventable and overdose management training, drug education and other preventive measures could help reduce mortality.

TL;DR: The trial failed to replicate earlier findings suggesting that methylphenidate was superior to placebo, and any replication of this work would need to consider alternatives to the rigid clinic attendance criteria, and consider an increased dose.